⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

Marsh & McLennan added a new risk factor in 2025 addressing healthcare industry-specific challenges, including regulatory and reputational concerns, reflecting increased exposure in that sector. The company substantively modified four existing risk factors, with notable updates to acquisition/disposal risks, technology and AI disruption threats, and ESG regulatory scrutiny, while maintaining 30 unchanged risks across its core operations.

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟢 New in Current Filing Our businesses are subject to a number of risks related to the U.S. healthcare industry, including risks related to healthcare regulation and reputational damage from negative publicity. 🔒

🟡 Modified We face risks when we acquire or dispose of businesses. 🔒

🟡 Modified Our business performance and growth plans could be negatively affected if we are not able to develop and implement improvements in technology or respond effectively to the threat of digital disruption and other technological change such as AI. 🔒

🟡 Modified Increasing scrutiny and changing laws and expectations from regulators, investors, clients and our colleagues with respect to our environmental, social and governance (ESG) practices and disclosure may impose additional costs on us or expose us to new or additional risks. 🔒

🟡 Modified Failure to maintain our corporate culture could adversely affect our business and reputation. 🔒

5 changes in this historical filing

Historical year-over-year comparisons (2025 vs 2024 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →